BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 24878112)

  • 1. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.
    Kerr SJ; Puthanakit T; Vibol U; Aurpibul L; Vonthanak S; Kosalaraksa P; Kanjanavanit S; Hansudewechakul R; Wongsawat J; Luesomboon W; Ratanadilok K; Prasitsuebsai W; Pruksakaew K; van der Lugt J; Paul R; Ananworanich J; Valcour V;
    AIDS Care; 2014; 26(11):1327-35. PubMed ID: 24878112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
    Chaudhury S; Williams PL; Mayondi GK; Leidner J; Holding P; Tepper V; Nichols S; Magetse J; Sakoi M; Moabi K; Makhema J; Mdluli C; Jibril H; Seage GR; Kammerer B; Lockman S
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28912368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3-5 years of age, exposed pre- and perinatally to anti-retroviral medications.
    Smith ML; Puka K; Sehra R; Read SE; Bitnun A
    AIDS Care; 2017 Oct; 29(10):1302-1308. PubMed ID: 28482682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopment of HIV-exposed uninfected children compared with HIV-unexposed uninfected children during early childhood.
    Young JM; Bitnun A; Read SE; Smith ML
    Dev Psychol; 2022 Mar; 58(3):551-559. PubMed ID: 35286108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study.
    Puthanakit T; Ananworanich J; Vonthanak S; Kosalaraksa P; Hansudewechakul R; van der Lugt J; Kerr SJ; Kanjanavanit S; Ngampiyaskul C; Wongsawat J; Luesomboon W; Vibol U; Pruksakaew K; Suwarnlerk T; Apornpong T; Ratanadilok K; Paul R; Mofenson LM; Fox L; Valcour V; Brouwers P; Ruxrungtham K;
    Pediatr Infect Dis J; 2013 May; 32(5):501-8. PubMed ID: 23263176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.
    Zhang X; Wang L; Han J; Xie L; Wu N; Nyirenda R; Shumba K; Simwanza W; Kulyk O; Chilapondwa V; Li X
    Int J Gynaecol Obstet; 2021 Jun; 153(3):424-437. PubMed ID: 33270235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Risk of Executive Function and Emotional Behavioral Problems Among Virologically Well-Controlled Perinatally HIV-Infected Adolescents in Thailand and Cambodia.
    Kerr SJ; Puthanakit T; Malee KM; Thongpibul K; Ly PS; Sophonphan J; Suwanlerk T; Kosalaraksa P; Ounchanum P; Aurpibul L; Kanjanavanit S; Ngampiyaskul C; Chettra K; Robbins R; Paul R; Ananworanich J; Mellins CA
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):297-304. PubMed ID: 31335589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental outcomes in young children born to HIV-positive mothers in rural Yunnan, China.
    Wu J; Li J; Li Y; Loo KK; Yang H; Wang Q; Duan R; Xiao X; Song X; Yang S; Sun L
    Pediatr Int; 2018 Jul; 60(7):618-625. PubMed ID: 29663621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant.
    Nulman I; Sgro M; Barrera M; Chitayat D; Cairney J; Koren G
    Paediatr Drugs; 2010 Apr; 12(2):113-22. PubMed ID: 20095652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
    Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
    AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early academic achievement of HIV-exposed uninfected children compared to HIV-unexposed uninfected children at 5 years of age.
    Young JM; Bitnun A; Read SE; Smith ML
    Child Neuropsychol; 2021 May; 27(4):532-547. PubMed ID: 33461418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapy.
    Laughton B; Cornell M; Kidd M; Springer PE; Dobbels EFM; Rensburg AJV; Otwombe K; Babiker A; Gibb DM; Violari A; Kruger M; Cotton MF
    J Int AIDS Soc; 2018 May; 21(5):e25106. PubMed ID: 29722482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopment in Young Children Born to HIV-Infected Mothers: A Meta-analysis.
    McHenry MS; McAteer CI; Oyungu E; McDonald BC; Bosma CB; Mpofu PB; Deathe AR; Vreeman RC
    Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29374109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cohort profile: longitudinal and population comparison of children who are HIV-exposed uninfected and children who are HIV unexposed in Kenya (HOPE study).
    Njuguna IN; King'e M; Moraa H; Kumar M; Benki-Nugent S; Wagner AD; McGrath CJ; Dorsey S; Ndegwa S; Onyango A; Wamalwa D; John-Stewart G
    BMJ Open; 2024 Jun; 14(6):e081975. PubMed ID: 38844397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status.
    Le Doaré K; Bland R; Newell ML
    Pediatrics; 2012 Nov; 130(5):e1326-44. PubMed ID: 23118140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
    Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
    Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.